Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

3A Paediatrics > Paediatric haematology > Flashcards

Paediatric haematology Flashcards

1
Q

What is the definition of anaemia?

A

A condition in which there is a deficiency of red cells or of haemoglobin in the blood to meet the body’s needs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Normal ranges for blood in children

A

slide 6 paediatric haematology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pathogenesis of anaemia

A
  • Blood loss
    Acute haemorrhage
    Chronic gut bleeding leading to iron deficiency
  • Decreased Production
    Nutritional deficiency e.g. iron, folate, B12, Vitamin C
    Bone marrow failure e.g. DBA, TEC
    Infiltration e.g. Acute Leukaemia, Neuroblastoma, Lymphoma, Osteopetrosis, Storage Disease
  • Increased consumption
    Acquired e.g. immune, drugs, parasites, MAHA
    Inherited e.g. red cell membrane defects, enzyme defects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the blood parameters?

A

Hb (always check normal range for age and sex)
Is the abnormality isolated to a single cell line or part of multiple cell lines (?BM failure, infiltration, immune, hypersplenism)
MCV (microcytic, normocytic, macrocytic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

EG of microcytic RBC conditions

A

Fe Deficient
Thalassaemia
Sideroblastic anaemia
Chronic disease
Lead toxicity
Copper deficiency
Haemoglobin E trait
Severe malnutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Macrocytic RBC

A

Newborn
Aplastic anaemia
Hypothyroidism
Megaloblastic anaemia
Increased erythropoiesis
Fanconi anaemia
PNH
Drugs
Post splenectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Normocytic RBC

A

Acute blood loss
Infection
Renal failure
Early Fe deficiency
Bone marrow infiltration
Haemolysis
Hyperslpensim
Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are reticulocytes?

A

Immature red blood cells
Typically 1% of RBC in humans
Develop in bone marrow and then circulate in blood for 1 day prior to developing into mature RBC.
Useful in establishing if marrow producing RBC effectively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are blood films?

A

Very helpful in the diagnosis of anaemia
It establishes if hypochromic, microcytic, normocytic, macrocytic
It shows specific morphological abnormalities e.g. spherocytes, sickle cells, elliptocytes, schistocytes etc.
Allows review of other cell lines also e.g. platelets, white blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Most common anaemia of childhood and what can cause it

A

Fe defi
LBW, dietary- excessive cows milk intake, occult GI bleeding (e.g. hookworm), cow’s milk intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Presentation of Fe deficiency

A

pallor, irritability, anorexia when Hb<50, tachycardia, cardiac dilatation, murmur, poss. splenomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blood results of Fe deficiency

A

microcytic, hypochromic, low-normal retics

Low ferritin and serum iron, Increased TIBC

High ZPP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment of Fe

A

ORAL THERAPY – Mainstay

Oral iron dose is 6mg/kg/day of elemental iron

reticulocytosis in 72 hr, Hgb responds at ~10g/L per wk, iron stores replenished by 3 mo

treatment is needed for 3-6 months
constipation common

commonest cause of failure is non-compliance
address cause- usually diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is haemolysis?

A

Increased RBC turnover, shortened RBC lifespan
RBCs are fragile- especially abnormal ones
Spleen filters out and breaks down senescent RBCs, and must work overtime, and can result in effective asplenia (e.g. in sickle cell)
RBC degradation products must be handled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the intra corpuscular causes of RBC destruction

A

Haemoglobin
Enzyme
Membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are extra corpuscular causes of destruction of RBC

A

Autoimmune
Fragmentation
Hyper splenism
Plasma factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Presentation of haemolytic anaemias

A

Hydrops fetalis
Neonatal hyperbilirubinaemia
Neonatal ascites
Anaemia/failure to thrive
Splenomegaly
Cholecystitis/gall stones
Hyperbilirubinaemia
Leg ulcers
Aplastic crisis
Thromboembolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Severe anaemia at birth features

A

Haemolytic disease of the newborn

Bleeding
umbilical cord
internal hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is haemolytic disease of the newborn?

A

Rh negative mother previously sensitised to Rh pos cells
Transplacental passage of antibodies
Haemolysis of Rh Pos fetal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

S + S of haemolytic disease of the newborn?

A

Signs and Symptoms
severe anemia
compensatory hyperplasia & enlargement of blood forming organs (spleen and liver)
Treatment
prevention of sensitization with Rh immune globulin
intrauterine transfusion of affected fetuses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the 3 main presentations of G6PD?

A

Neonatal jaundice
Chronic non-spherocytic haemolytic anaemia
Intermittent episodes of intravascular haemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Features of G6PD

A

Sporadic haemolysis
Typically induced by drugs, fava beans, fever, acidosis
Intravascular haemolysis - haemoglobinuria, rigors, fever, back pain
Treated by stopping precipitant, transfusion, renal support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Features of hereditary spherocytosis

A

Commonest hereditary haemolytic anaemia in Europeans - 1/5000; probably rarer in Africa
Typically autosomal dominant, but no family history in 25% cases
Heterogeneous - deficiencies of spectrin (41.5%), ankyrin (1.5%), band 3 (17%), band 4.2 (21.5%)
Clinical effects vary from mild to transfusion dependence; tends to be similar within families

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is sickle cell disease?

A

The most common serious genetic disorder in England affecting over 1 in 2000 live births. (Autosomal recessive)
A term covering a number of different but similar conditions that affect haemoglobin.
Types most commonly seen in UK:
Sickle Cell Anaemia (HbSS)
Sickle Haemoglobin C disease (HbSC)
Sickle Beta Thalassaemia (HbS/β thal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pathophysiology of sickle cell disease

A

Substitution of valine for glutamic acid on β chain (HbS)
HbS polymerises when deoxygenated leading to sickle shape
Occlusion of the microvascular circulation producing vascular damage, infarcts, pain
Shortened survival of red cells leading to haemolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How will we diagnose sickle cell disease?

A

Blood Film
Sickle solubility
HPLC

27
Q

What can we do to treat sickle cell disease?

A

Education – keeping warm, well hydrated
Prophylactic Penicillin V to prevent infection due to splenic hypofunction (anti malarials when required)
Ensure immunisations are up to date to prevent infection
Screening such as TCD monitoring, G+M
Effective pain management (NICE requirement)
Prompt treatment of infections
Bone Marrow Transplant
Hydroxycarbamide
New agents e.g. Crizanlizumab, L-Glutamine

28
Q

What are some complications of HbSS

A

Enuresis
Priapism
Avascular necrosis
Chronic ankle ulceration

29
Q

What is thalassaemia?

A

Normal Adult HbA = α2β2,
HbA2 = α2δ2
HbF = α2γ2
Thalassaemia = reduced rate of one or more of the globin chains
Autosomal recessive
α thal (4 α globin genes per cell αα/αα)
β thal (2 globin genes per cell)

30
Q

What is Beta thalassaemia

A

β Thalassaemia Trait ( carrier state)
asymptomatic
Mild anaemia, low MCV, Raised Hb A2

31
Q

Features of B Thalassaemia

A

β Thalassaemia Major
Progressive Severe Anaemia, low MCV, Hb F and A2 increased
Jaundice
Splenomegaly
Failure to thrive
Skeletal Deformity
Delayed puberty
Death early teens/adulthood

32
Q

B Thalassaemia management

A

Genetic Counselling, AN diagnosis
Regular blood transfusion
Complications of Iron overload
Liver, Heart, Pancreas, Endocrinopathy
Iron chelation
Bone Marrow Transplantation/Gene Therapy

33
Q

What is haemostasis and what does it depend on?

A

Coagulation cascade - pl
Platelets
Numbers
Function
Coagulation factors
Vascular integrity

34
Q

Coagulation cascade

A

Slide 35 Paediatric haematology

35
Q

Factors involved in Intrinsic pathway

A

Prekallikrein
HMWK
FXII
FXI
FIX
FVIII

36
Q

Factors involving Extrinsic pathway

A

FVII

37
Q

Common pathway in coag cascade

A

FV
FX
Prothrombin
Fibrinogen

38
Q

What are the causes of thrombocytopenia

A

Increased Plt destruction (Immune and non immune)
Dec Platelet production
Disorders of platelet pooling
Pseudothrombocytopenia

39
Q

What causes increased PLT destruction (IMMUNE) in thrombocytopenia

A

ITP
Secondary to infection (HIV, Hepatitis, CMV, EBV, Parvovirus, mumps, measles, pertussis)
Drug induced – valproate, ciprofloxacin, ibuprofen, phenytoin, ranitidine, heparin, captopril
Autoimmune –Evans syndrome
SLE
NAIT
Hyperthyroidism

40
Q

What causes increased plt destruction (Non immune) in thrombocytopenia

A

Microangiopathic (TTP, HUS)
Kasabach-Merritt Syndrome
Drugs
Infection (viral associated haemophagocytic syndrome) (bacterial infection)
Disseminated Intravascular Haemolysis

41
Q

What causes decreased platelet production in thrombocytopenia

A

Constitutional (TAR, CAMT)
Ineffective thrombopoiesis ( B12, Folate Deficiency, severe iron deficiency))
Infiltration (Leukaemia, Non haem infiltration, Osteopetrosis, storage disease)
Metabolic disorders (Ketotic glycinaemia, MMA, Acidaemia)
Bone Marrow Failure (Aplastic Anaemia)

42
Q

What are some disorders of platelet pooling

A

Hypersplenism (Portal Hypertension, Gauchers disease)

43
Q

What is pseudo thrombocytopenia?

A

Platelet activation during blood collection

44
Q

What is the most common form immunologic thrombocytopenia

A

ITP

45
Q

Features of ITP

A

Identified if well child, acute onset and no other concerning features, history with normal examination (other than bruising, petechiae etc)
Important to review blood film periodically to ensure no evolving serious bone marrow disorder
Acute 0-3 months
Persistent >3-12 months
Chronic >12 months
Treatment rarely required unless bleeding – steroids, IVIG, TPO-RA

46
Q

What are coagulopathies

A

Various errors in clotting cascade
Bleeding disorders
hemophilia
von Willebrand disease
Hypercoagulable states
antithrombin, protein C, protein S, FVL, PT mutation, APS

47
Q

What is Von willebrand disease

A

VWD is the commonest inherited bleeding disorder that varies in severity according to the degree of deficiency and the specific characters of the molecule that is altered.

48
Q

WHAT ARE THE 2 MAIN ROLES OF VWF?

A

Mediates the adherence of platelets at sites of endothelial damage helping form platelet plug
Binds and transports FVIII, protecting it from degradation

49
Q

What is the deficiency in VWD?

A

Deficiency of VWF (type 1)
Dysfunction of VWF (type 2A, B, M,N)
Complete absence of VWF (type 3)

50
Q

S + S of VWD?

A

Easy bruising
Epistaxis
Menorrhagia
Mucosal bleeding
Following surgery or trauma

50
Q

how IS vwd INHERITED?

A

AD or AR for type 3 or 2N

51
Q

How can we investigate VWD?

A

Clotting often shows prolonged APTT (not always!)
VWD screen – FVIII, VWF:Ag, VWF activity
Further investigations can be performed to identify type 1 from 2
Function:antigen ratio <0.6
RIPA
Multimer Analysis
Genetic analysis

52
Q

How do we manage VWD?

A

Tranexamic Acid
An antifibrinolytic useful for menorrhagia or mucosal bleeding
Given pre procedures IV 10mg/kg and orally 15-25mg/kg tds for other bleeding or post operatively

Desmopressin
Used to elevate FVIII and VWF levels by releasing endothelial stores.
Given IV, SC or intranasal
Perform a DDAVP trial if possible to assess response
Excessive fluid intake can reduce sodium so restrict fluid to 1L for 24 hours post dose
Avoid use if <2 years or monitor sodium closely and avoid if know atherosclerosis
Avoid in Type 2B as thrombocytopenia due to clearance of large multimers.

VWF- containing concentrates
Given if DDAVP inadequate or contraindicated
Voncento, Wilate
Given as IV bolus 12-24 hours as required by bleeding and levels.
Plasma products so ensure hepatitis vaccinations given pre where possible

53
Q

What are Haemophilia A and B and what does it cause?

A

Deficiency of Factor VIII/IX, ↑APTT
X linked recessive- boys
Prolonged bleeding
Muscle bleeds
Joint bleeds > arthritis and deformity
Treatment Factor VIII/IX
Complications of treatment

54
Q

Presentation of severe moderate and mild haemophilia

A

Severe - <1IU/dl or <1% of normal
Spontaneous bleeding into joints or muscles

Moderate - 1-5IU/dl or 1-5% of normal
Occasional spontaneous bleeding, prolonged bleeding with minor trauma or surgery

Mild - 5-40IU/dl or 5-40% of normal
Severe bleeding with major trauma or surgery. Spontaneous bleeding rare

55
Q

How do we manage the bleeding in haemophilia?

A

Tranexamic Acid
Factor concentrate( standard life and extended half life) – recombinant e.g. Advate, Benefix, Elocta
Emicizumab (recombinant humanised bispecific monoclonal antibody mimicking the co-factor of activated FVIII)

56
Q

When does leukaemia occur?

A

When WBC starts multiplying out of control

57
Q

Common symptoms of leukaemia

A

Weight loss
Fever
Infection
Fatigue
Loss of appetite
Spleen and liver enlargement
Anaemia
Bone joint paint
Purple patches or spots
Night sweats

58
Q

Types of paediatric leukaemia

A

ALL - 85%
AML - 13%
Others - 2%

59
Q

How do we make the diagnosis of ALL

A

Blood count Anaemia
WCC up or down
Neutropaenia
Thrombocytopaenia
Blast cells
Bone Marrow
LP

60
Q

Features of ALL

A

Most common malignancy
Peak age 4-7yrs
Prognosis 85% cure
Good Prognostic factors
Age 2-10
Female
WCC<50
No CNS disease
Classified also on cell type B and T cell

61
Q

Treatment for leukaemia

A

Supportive
Prompt treatment of infection
Prevention of tumour lysis
Blood product support
Specific
Chemotherapy (ALL – Altogether, AML – Myechild)
Targeted therapy
Bone marrow transplant

62
Q

Late effects of treatment

A

Psychological
Family and social
Growth particularly CNS RT
Endocrine
Puberty
Fertility
Intellectual
Second malignancies

3A Paediatrics (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions